Han van den Bosch

1.4k citations

26 papers · 1.1k indexed · h-index 19

Co-authors: Paul van Empel Joachim Frey P. J. Blackall P. K. Storm Peter Kuhnert H. L. B. M. Klaasen Jacco Heldens Danny Goovaerts
Topics: Influenza Virus Research Studies (10 papers)Microbial infections and disease research (10 papers)Respiratory viral infections research (6 papers)
Cited by: Microbiology Immunology Pharmaceutical Science
Journals: Journal of Bacteriology Journal of Controlled Release Journal of Clinical Microbiology
Partner nations: United States Netherlands Russia

In The Last Decade

Han van den Bosch

25 papers receiving 1.0k citations

Peers

Countries citing papers authored by Han van den Bosch

Since Specialization

Citations

This map shows the geographic impact of Han van den Bosch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han van den Bosch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han van den Bosch more than expected).

Fields of papers citing papers by Han van den Bosch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han van den Bosch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han van den Bosch. The network helps show where Han van den Bosch may publish in the future.

Co-authorship network of co-authors of Han van den Bosch

This figure shows the co-authorship network connecting the top 25 collaborators of Han van den Bosch. A scholar is included among the top collaborators of Han van den Bosch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han van den Bosch. Han van den Bosch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: A Phase I dose escalating study in healthy volunteers 2014 ·Vaccine ·Jacco Heldens,Ellen G. J. Hulskotte,(unknown),(unknown),Paul E. Verweij,Wilbert van Duijnhoven,(unknown),Pierre Van Damme,Han van den Bosch	7
2	Characterization of Reverse Genetics-Derived Cold-Adapted Master Donor Virus A/Leningrad/134/17/57 (H2N2) and Reassortants with H5N1 Surface Genes in a Mouse Model 2014 ·Clinical and Vaccine Immunology ·Irina Isakova–Sivak,Limei Chen,Melissa Bourgeois,Yumiko Matsuoka,J. T. M. Voeten,J.G.M. Heldens,Han van den Bosch,Alexander Klimov,Larisa Rudenko,Nancy J. Cox,Rubén O. Donis	12
3	Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2) 2011 ·Virology ·Irina Isakova–Sivak,Li-Mei Chen,Yumiko Matsuoka,J. T. M. Voeten,Irina Kiseleva,Jacco Heldens,Han van den Bosch,Alexander Klimov,Larisa Rudenko,Nancy J. Cox,Rubén O. Donis	80
4	A step-by-step approach to study the influence of N-acetylation on the adjuvanticity of N,N,N-trimethyl chitosan (TMC) in an intranasal nanoparticulate influenza virus vaccine 2011 ·European Journal of Pharmaceutical Sciences ·Rolf J. Verheul,Niels Hagenaars,(unknown),Ethlinn V.B. van Gaal,(unknown),Sven C. M. Bruijns,Enrico Mastrobattista,Bram Slütter,Ivo Que,Jacco Heldens,Han van den Bosch,Harrie L. Glansbeek,Wim E. Hennink,Wim Jiskoot	11
5	Comparative Immunogenicity and Cross-Clade Protective Efficacy of Mammalian Cell-Grown Inactivated and Live Attenuated H5N1 Reassortant Vaccines in Ferrets 2011 ·The Journal of Infectious Diseases ·Kortney M. Gustin,Taronna R. Maines,Jessica A. Belser,Neal Van Hoeven,Xiaoyan Lu,L. Y. Dong,Irina Isakova–Sivak,Liming Chen,J. T. M. Voeten,Jacco Heldens,Han van den Bosch,(unknown),Terrence M. Tumpey,(unknown),Larisa Rudenko,Rubén O. Donis,(unknown)	38
6	Live attenuated pandemic influenza vaccine: Clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries 2011 ·Vaccine ·Larisa Rudenko,Han van den Bosch,Irina Kiseleva,(unknown),(unknown),Natalie Larionova,(unknown)	47
7	Leading role of genes coding polymerase complex in attenuation of domestic donor viruses for A and B Live Influenza Vaccine 2010 ·Journal of Microbiology Immunology and Infection ·Irina Kiseleva,Natalie Larionova,J. T. M. Voeten,(unknown),(unknown),J.G.M. Heldens,Han van den Bosch,Larisa Rudenko	0
8	Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model 2010 ·Archives of Virology ·J. T. M. Voeten,Irina Kiseleva,Harrie L. Glansbeek,(unknown),(unknown),Larisa Rudenko,Han van den Bosch,Jacco Heldens	6
9	Role of trimethylated chitosan (TMC) in nasal residence time, local distribution and toxicity of an intranasal influenza vaccine 2010 ·Journal of Controlled Release ·Niels Hagenaars,(unknown),(unknown),Ivo Que,(unknown),Bram Slütter,Harrie L. Glansbeek,Jacco Heldens,Han van den Bosch,Clemens W.G.M. Löwik	54
10	Relationship between structure and adjuvanticity of N,N,N-trimethyl chitosan (TMC) structural variants in a nasal influenza vaccine 2009 ·Journal of Controlled Release ·Niels Hagenaars,Rolf J. Verheul,(unknown),(unknown),Enrico Mastrobattista,Harrie L. Glansbeek,Jacco Heldens,Han van den Bosch,Wim E. Hennink,Wim Jiskoot	49
11	Physicochemical and Immunological Characterization of N,N,N-Trimethyl Chitosan-Coated Whole Inactivated Influenza Virus Vaccine for Intranasal Administration 2009 ·Pharmaceutical Research ·Niels Hagenaars,Enrico Mastrobattista,Rolf J. Verheul,(unknown),Harrie L. Glansbeek,Jacco Heldens,Han van den Bosch,Wim Jiskoot	47
12	Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: Effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model 2008 ·Vaccine ·Niels Hagenaars,Enrico Mastrobattista,Harrie L. Glansbeek,Jacco Heldens,Han van den Bosch,Virgil E.J.C. Schijns,Didier Betbeder,Herman Vromans,Wim Jiskoot	65
13	Subunit vaccines based on intimin and Efa-1 polypeptides induce humoral immunity in cattle but do not protect against intestinal colonisation by enterohaemorrhagic Escherichia coli O157:H7 or O26:H- 2007 ·Veterinary Immunology and Immunopathology ·Pauline M. van Diemen,Francis Dziva,(unknown),T. S. Wallis,Han van den Bosch,Gordon Dougan,N. Chanter,Gad Frankel,Mark P. Stevens	46
14	Comparison of the efficacy of a subunit and a live streptomycin‐dependent porcine pleuropneumonia vaccine 2004 ·Australian Veterinary Journal ·(unknown),(unknown),Han van den Bosch,(unknown),(unknown),(unknown),P. J. Blackall	40
15	Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs 2003 ·Vaccine ·Han van den Bosch,Joachim Frey	36
16	Proposal of a new serovar of Actinobacillus pleuropneumoniae: serovar 15 2002 ·Veterinary Microbiology ·P. J. Blackall,H. L. B. M. Klaasen,Han van den Bosch,Peter Kuhnert,Joachim Frey	182
17	Immunohistochemical and serological investigation of experimentalOrnithobacterium rhinotrachealeinfection in chickens 1999 ·Avian Pathology ·Paul van Empel,Mieke P. Vrijenhoek,Danny Goovaerts,Han van den Bosch	28
18	Identification and serotyping of Ornithobacterium rhinotracheale 1997 ·Journal of Clinical Microbiology ·Paul van Empel,Han van den Bosch,(unknown),P. K. Storm	92
19	Experimental infection in turkeys and chickens with Ornithobacterium rhinotracheale. 1997 ·PubMed ·Paul van Empel,Han van den Bosch,Danny Goovaerts,P. K. Storm	61
20	Localization of antigenic determinants on P-fimbriae of uropathogenicEscherichia coli 1988 ·FEMS Microbiology Letters ·Irma van Die,N. Riegman,(unknown),(unknown),W. P. M. Hoekstra,Hans Bergmans,(unknown),Han van den Bosch	16

About Han van den Bosch

Han van den Bosch is a scholar working on Microbiology, Endocrinology and Pharmaceutical Science, having authored 26 papers that have together received 1.1k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (10 papers), Microbial infections and disease research (10 papers) and Respiratory viral infections research (6 papers). The work is most often cited by research in Microbiology (552 citations), Immunology (461 citations) and Pharmaceutical Science (108 citations). Han van den Bosch has collaborated with scholars based in United States, Netherlands and Russia. Frequent co-authors include Paul van Empel, Joachim Frey, P. J. Blackall, P. K. Storm, Peter Kuhnert, H. L. B. M. Klaasen, Jacco Heldens, Danny Goovaerts, Harrie L. Glansbeek and Niels Hagenaars. Their work appears in journals such as Journal of Bacteriology, Journal of Controlled Release and Journal of Clinical Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact